Stevens-Johnson syndrome/toxic epidermal necrolysis: international consensus, advances and opportunities

Affiliations

Editorial

Daniel F Carr et al. Br J Dermatol. 2024.

. 2024 Dec 23;192(1):4.

doi: 10.1093/bjd/ljae358.

¹ Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.

No abstract available

Conflict of interest statement

Conflicts of interest The authors declare no conflicts of interest.

Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.
Hama N, Aoki S, Chen CB, Hasegawa A, Ogawa Y, Vocanson M, Asada H, Chu CY, Lan CE, Dodiuk-Gad RP, Fujiyama T, Hsieh TS, Ito K, Jerschow E, Mizukawa Y, Nakajima S, Nakamura K, Nicolas JF, Satoh TK, Shiohara T, Takahashi H, Tohyama M, Ueda T, Ura K, Watanabe H, Yamaguchi Y, Nordmann TM, Chung WH, Naisbitt D, Pincelli C, Pichler WJ, French LE, Phillips E, Abe R. Hama N, et al. Br J Dermatol. 2024 Dec 23;192(1):9-18. doi: 10.1093/bjd/ljae321. Br J Dermatol. 2024. PMID: 39141587 Review.